Archives for 20 Sep,2018

You are browsing the site archives by date.

Efficacy and safety of semaglutide for weight loss in patients with obesity

In this paper, published in The Lancet, the authors sought to assess efficacy and safety of the glucagon-like peptide-1 (GLP-1) analogue semaglutide, in comparison with a similar drug liraglutide, and placebo. The study was done in 8 countries, involving...
Read More

Does environment influence childhood BMI? A study of children aged 3–11

Obesity is simply caused by an imbalance in energy consumed and calories burned, however what causes this imbalance is complex and multifactorial. If enough calories are burned through physical activity, then an individual should not gain weight. Following...
Read More

Obesity and loss of disease-free years owing to major non-communicable diseases

Obesity is known to be associated with an increased risk of several major non-communicable diseases including type-2 diabetes, coronary heart disease, stroke, asthma and several cancers. It was previously thought that metabolically healthy obese (MHO)...
Read More